NY2LA, Inc
✅ Low Risk
FEI: 3007521479 • Camarillo, CA • UNITED STATES
FEI Number
3007521479
Location
Camarillo, CA
Country
UNITED STATESAddress
758 Calle Plano, , Camarillo, CA, United States
Low Risk
FDA Import Risk Assessment
This firm has a minimal history of FDA import refusals with low-severity violations.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
NOT LISTED
It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 4/3/2015 | 86HQZFRAME, SPECTACLE | 118NOT LISTED | Florida District Office (FLA-DO) |
Frequently Asked Questions
What is NY2LA, Inc's FDA import refusal history?
NY2LA, Inc (FEI: 3007521479) has 1 FDA import refusal record(s) in our database, spanning from 4/3/2015 to 4/3/2015.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. NY2LA, Inc's FEI number is 3007521479.
What types of violations has NY2LA, Inc received?
NY2LA, Inc has been cited for 1 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about NY2LA, Inc come from?
All FDA import refusal data for NY2LA, Inc is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.